Lingrui Pharmaceuticals Hosts the 2024 Xin County Half Marathon on March 31st

The 2024 Xin County Half Marathon will feature two events: a 21.0975km half marathon with 4,000 participants and a 5.2km fun run and parent-child run with 6,000 participants. Notably, 40% of the 10,000 athletes and sports enthusiasts will come from 18 other provinces across China.

Since its debut in 2018, the Xin County Half Marathon has successfully held four editions, attracting over 30,000 participants. For this year's event, the title sponsor Lingrui Pharmaceutical is providing all participants with generous gifts, including Tongluo Pain Relief Cream, Lingrui Indomethacin Patch, and Lingrui Chongcaojun.

Xiding Conference | Lingrui Two Tigers Listed on the Chinese Pharmaceutical Retail Market Brand List

On March 21, 2024, amidst the vibrant spring in Danzhou, Hainan, the 9th Health Commodity Trading Conference (2024 Xiding Conference) commenced. At the event, Lingrui Two Tigers was honored with the "Best-selling Brand in China's Pharmaceutical Retail Market" award, while Lingrui Little Antelope Medical Cooling Patch received the "Potential Brand in China's Pharmaceutical Retail Market" award.

The "Best-selling brands" category recognizes well-known brands across various sectors that have a strong presence in the retail market, significant sales, high penetration, and substantial customer orders—factors that ensure both revenue and customer flow in the terminal market. Products like Lingrui Two Tigers boast penetration rates exceeding 4%, with high-penetration brands serving as a fundamental guarantee for store traffic.

Since its inception in 2016, the Xiding Conference has grown into a pivotal platform for the dissemination of forward-looking commodity information, precise commodity transactions, and corporate brand showcases within China's health industry. During this year's conference, the Lingrui Pharmaceutical exhibition hall garnered considerable attention from industry professionals. The company’s Two Tigers series plasters and Little Antelope Medical Cooling Patches, along with other children's products in the Little Antelope series, attracted chain merchants nationwide for discussions and negotiations. Moving forward, Lingrui Pharmaceutical is committed to advancing industrial innovation through technological advancements, striving to establish a high-quality traditional Chinese medicine brand, and safeguarding public health with safe and effective medications.

Lingrui Pharmaceutical and Jiuzhoutong Pharmaceutical Group Hold Strategic Cooperation Meeting

In early March 2024, Henan Lingrui Pharmaceutical Co., Ltd. (Lingrui Pharmaceutical) and Jiuzhoutong Pharmaceutical Group held a strategic cooperation meeting. The two companies engaged in in-depth discussions about exploring potential collaborations and expanding their cooperation in the future.

2024 "Dragon Head Raising, Neck Relaxation" National Health Service Charity Event

On March 11, the second day of the second month of the lunar calendar, Lingrui Pharmaceutical held its 2024 National "Dragon Head-Raising · Neck Relaxation" health service event at the main venue in Xin County, Henan Province, deep in the Dabie Mountains.

This public health service activity aimed to enhance health awareness among the public and encourage good health habits. The event, which started on March 9 and lasted for four days, took place in over 300 cities across the country. It promoted cervical health care knowledge through on-site demonstrations of "unblocking meridians + activating blood circulation," patch massages, interactive Q&A sessions, and more, allowing the public to better understand cervical health and experience the benefits of traditional Chinese medicine firsthand.

Lingrui Pharmaceuticals Partners with China Railway for Brand Marketing

At the start of 2024, Lingrui Pharmaceuticals reignited its plaster brand promotion campaign. The company has strategically deployed its marketing across China’s general railway network, marking the beginning of a comprehensive brand marketing effort for the new year.

China's extensive railway network connects major cities and small towns, serving as a powerful platform to reach a broad audience, including travelers, students, and families. By showcasing the Lingrui Two Tigers brand on trains frequently and over long periods, Lingrui Pharmaceuticals can effectively convey its brand message to passengers, making a lasting impression on target consumers.

This strategic partnership between Lingrui Pharmaceuticals and China Railway will undoubtedly help expand the Two Tigers brand nationwide, revitalizing its market presence and boosting its brand influence.

Lingrui Pharmaceuticals Boosts Biopharmaceutical Industry in Xin County, Henan Province

On December 15, 2023, at the First TCM (Traditional Chinese Medicine) Ecological Conference and TCM Industry Expo, the "Top 50 Comprehensive Competitiveness Index of Traditional Chinese Medicine Enterprises in 2023" was announced. Lingrui Pharmaceutical proudly secured the 28th spot, achieving a comprehensive score of 322.91 across three criteria.

From January to November 2023, Lingrui Pharmaceutical generated a tax revenue of 464 million yuan. The company's "Two Tigers" series of plasters have achieved an annual sales volume of over 1 billion patches. Lingrui has been honored with over 20 provincial and national recognitions, including "National Key High-tech Enterprise" and "National Intelligent Manufacturing Digital Factory," and has been designated a "National Technology Innovation Demonstration Enterprise" by the Ministry of Industry and Information Technology.

As a leader in the health industry cluster in Xin County, Henan Province, Lingrui Pharmaceutical has successfully established the Henan Provincial Institute of Modernized Traditional Chinese Medicine Industry, the Innovation Consortium, and the Provincial Key Laboratory of Transdermal Drug Delivery Preparations. In 2023, the Lingrui Biological External Ointment Automated Production Line Upgrading and Renovation Project, a key provincial project, was put into production.

Lingrui Pharmaceutical comes away with several awards at the 2023 Wuzhen Health Conference

From April 9th to 13th, 2023, the 2023 Wuzhen Health Conference and the 2nd China OTC Conference was held in Wuzhen, Jiaxing, Zhejiang. Lingrui Pharmaceutical was awarded the "Anti-pandemic Guarantee Supply Responsibility Enterprise". Its star products, Two-Tiger®️ Musk Bone-strengthening and Pain-relieving Plaster Patch and Pediatric Fever Relieving Patch won the "West Lake Award Most Popular Star Items in Pharmacies".

As the star product in Lingrui Two Tigers®️ plaster series, the Musk Bone-strengthening and Pain-relieving Plaster Patch accounts for as high as 92% of same-category market share in 2022. Deeply trusted and favored by consumers, it was selected as "the most popular star item in pharmacies", "the brand with the highest recommendation rate by Chinese pharmacy clerks", and "the list of 600 essential brands for pharmacy management".

Pediatric Fever Relieving Patch is another product championed by Lingrui as the ideal choice for adjuvant treatment and physical cooling of multi-cause fevers. Statistics show that among similar products, the domestic market share of L Pediatric Fever Relieving Patch ranks in the top 2.

In addition to winning multiple commendations at the West Lake Awards, 6 products including Meridian Obstruction Removing and Pain Relieving Plaster Patch (Bone Hyperostosis Relief Plaster),  Musk Bone-strengthening and Pain-relieving Plaster Patch, Pain Relieving Plaster Patch for Injury and Rheumatism, Pain-Relieving Tincture, Joint Pain Relief Plaster Patch, and Muskiness Analgesic Plaster Patch made it onto the list of "Comprehensive Statistical Ranking of Chinese Proprietary Medicines for Non-prescription Drug Products in China in 2022" at the 2nd China OTC Conference.

The conference also set up the "West Lake Award Innovative Marketing Cases", with the goal of recognizing and commending pharmaceutical companies that have achieved market breakthroughs and brand enhancements in innovative ways, setting industry benchmarks and promoting the common development of the industry. Lingrui Pharmaceuticals rolled out a comprehensive and three-dimensional promotion of the Two Tigers®️ brand, attracting more young people to consider and understand traditional Chinese medicine. "Two-Tiger Brand Casting" won the "West Lake Award Innovative Marketing Case".

In 2023, while continuing to invest in innovative research and development, the company will continue to make efforts to build the Two-Tiger brand. Through various channels and methods, it carries out public welfare science popularization activities for rheumatism, sprains, muscle pain, arthralgia, cervical spondylosis and other orthopedic diseases with a variety of innovative and exciting product combinations.

The 2023 Xin County Half Marathon sponsored by Lingrui Pharmaceuticals held with huge success

On April 9, 2023, the 2023 New County Half Marathon kicked off with an amazing 152 company members participating in this exciting competition. A post-match service area was set up to greet contestants at the finish line, providing rejuvenating massage and stretching for the players.

Lingrui’s famous product, the "Meridian Obstruction Removing and blood circulation", was the centerpiece of an event care package provided to better the health of all players participating in the event – sending home the message that the Lingrui brand of health and vitality would be a force to be reckoned with in the arena of sports and fitness.

In recent years, Lingrui Pharmaceutical has been continuously reinforcing their presence in the areas of injury treatment and care products in competitive sports. It has participated in the 2019 Zhengzhou International Marathon, 2019 Xinyang International Marathon, "Lingrui Cup" 2020 Dingli Central Plains Online Marathon Series, 2021 14th Zhengkai Marathon and other prestigious events – giving competitors a taste of Lingrui's professional and rich after-match services, and last but not least truly feel the care and effectiveness of high-quality products from Lingrui.

In the future, Lingrui endeavors to continue making huge strides in the sports market, developing more products for the treatment and care of sports injuries, and continuously improving the user experience and comfort of their products.

Lingrui Pharmaceutical Awarded Multiple Industry Honors at 2022 West Lake Forum

Lingrui Pharmaceutical was invited to participate the grandiose West Lake Forum, held in Wuzhen, China from June 27th to 30th 2022. Deputy General Manager of Lingrui Pharmaceuticals Wu Huibin, as well as the Chairman and General Managers of Lingrui Pharmaceuticals attended the launch ceremony as esteemed guests.

This would be the 10th annual West Lake Forum since its founding in 2013. In the spirit of "Gathering Potential and Leading Change", the Forum serves to promote industrial synergy and integrated development, assisting medical and health enterprises with greater flexibility and adaptability, digital advancement and high-quality development under the new rules of the industry.

Lingrui was awarded a number of industry honors during the West Lake Forum:

• “Most Popular Corporate Brand Award for Pharmacies"

• "Innovative Marketing Case Award" - Meridian Obstruction Removing and Pain-Relieving Plaster Patch (Bone Hyperostosis Relief Plaster) and Two-tiger Musk Bone-strengthening and Pain-relieving Plaster Patch

• Won the "Most Popular Pharmacy Star Single Product Award"

• As a VIP strategic cooperative enterprise of West Lake Forum, West Lake's ten-year "Smooth Award"

• "China Pharmaceutical Industry Pioneer” awarded to Wu Huibin

• "China Pharmaceutical Outstanding Brand Officer" awarded to Xu Dong

The bestowal of these multiple honors is a mark of high recognition of the Lingrui brand, as well as the Two-tiger brand by the pharmaceutical and health industry at large.

Live experience, rave reviews

During the forum, Lingrui Pharmaceutical's booth not only displayed products such as their Bone Hyperostosis Relief Plaster, Two-Tiger Series Plasters, Antelope Pediatric Fever Relieving Patch, and Biopharmaceutical Ointment, but courteous volunteers also provided massage and compression therapy for guests. The combination of the products "unblocking collaterals + activating blood circulation" provided guests with a comforting sensation unlike any other.

Moving forward and meeting the future, hand-in-hand

The West Lake Forum has once again come to a successful conclusion. Going forward, Lingrui will continue to join hands with a myriad of pharmaceutical retail partners to make new and exciting contributions to the high-quality development of the pharmaceutical and health care industry, as well as the preservation of personal health and wellness.

Lingrui Pharmaceutical Selected for One of China's Top 100 Non-Prescription Drugs 2021

2021 Healthy China - The First China OTC Conference and China Traditional Chinese Medicine Promotion Conference was held in Guangzhou from October 18-21, 2021. During the conference, the "2021 China Non-prescription Drug Product Comprehensive Statistics Rankings" were released, where Lingrui Pharmaceutical ranked 25th; Six Lingrui products were included in the top 20 list of Chinese patent medicines in orthopedics and traumatology. These included the Meridian Obstruction Removing and Pain Relieving Plaster Patch (Bone Hyperostosis Relief Plaster), Musk Bone-strengthening and Pain-relieving Plaster Patch, Pain Relieving Plaster Patch for Injury and Rheumatism, Joint Pain-relieving Plaster Patch, Musk Bone-strengthening Plaster Patch and Pain-Relieving Tincture.

The China OTC Conference is a professional comprehensive forum for the pharmaceutical industry. It is hosted by the China Over-the-Counter Drug Association and co-hosted by Xinhuanet and the China National Brand Network.

As one of the leading companies in the field of orthopedic plasters in China, Lingrui Pharmaceutical always places their focus on common ailments of the Chinese people's bone and joints, such as the cervical spine, lumbar spine and knee joints. The featured product, the Meridian Obstruction Removing and Pain-Relieving Plaster Patch (Bone Hyperostosis Relief Plaster) is both an exclusive and nationally protected product of traditional Chinese medicine. Since its launch, it has garnered a trusted reputation with "phubbers" and patients with osteoarthropathy. It has been successively rated as one of the "Most Popular Rheumatology Orthopedic Medicines" and as a "Top Ten Brand of Chinese Patent Medicine in Orthopedics" by industry experts.

Lingrui Pharmaceutical always adheres to the corporate philosophy of " Sincerity and the benefit of mankind ". It strongly emphasizes the development of the medical and health industry and strives to continue leading the charge with innovation. It will continue to provide patients with a better experience and make greater contributions to the prosperity and development of OTC as well as to the healthcare industry.

2021 CHEO Conference

2021 CHEO Conference: Lingrui Pharmaceutical was elected as a "Top 100 Enterprise in Comprehensive Competitiveness Index of Pharmaceutical Industry" as well as a part of the “Top 50 Companies in Chinese Patent Medicine of Pharmaceutical Industry Comprehensive Competitiveness Index”

The 2021 CHEO Conference was held at the Boao Asia Forum Hotel in Hainan Province from September 23rd to 28th. CHEO, abbreviated from the full name of China Health (International) Ecology Organization is sponsored by Zhongkang Technology. A forward-looking industry conference with the highest specifications, it boasts the largest scale as well as having one of the strongest influences in China's health industry. 

On September 25, 2021, Zhongkang Technology authoritatively released the CHEO Index at the conference, namely the 2020-2021 Pharmaceutical Industry Development Index as well as the Pharmaceutical Industry Comprehensive Competitiveness Index.

Currently compiled and published by Zhongkang Technology, the CHEO lndex describes data obtained by establishing a unified standardized evaluation model through continuous monitoring of industrial economic operation. It also takes into account the most competitive and influential core indicators of enterprise and brand clusters in a specific period of time. This includes the pharmaceutical industry development index (including the comprehensive competitiveness index of the pharmaceutical industry), the pharmaceutical retail industry development index (including the comprehensive competitiveness index of pharmaceutical retail enterprises) and the health industry۰ brand development index tri-series of index components. It comprehensively, intuitively, and objectively reflects the development of the industry and the competitiveness of the enterprise in question.

The pharmaceutical industry development index assesses the overall growth trend of the pharmaceutical industry and the fluctuation of core operating indicators. Taking into account the four dimensions of "industry investment, revenue level, profitability, and export trade", the comprehensive competitiveness index of the pharmaceutical industry reflects the comprehensive competitiveness of China's domestic pharmaceutical industry companies based on the six-force model of "commercialization, R&D, product, brand, productivity, and profitability".

Lingrui Pharmaceutical was elected as one of the "Top 100 Enterprises in Comprehensive Competitiveness Index of Pharmaceutical Industry" and “Top 50 Companies in Chinese Patent Medicine of Pharmaceutical Industry Comprehensive Competitiveness Index”. Lingrui was also awarded the "Health Industry ∙ Brand Development Index Top Brand" distinction. This is the 12th consecutive year that the Lingrui brand has won this award.

Three Activities of August 2020 for Lingrui Pharmaceutical

In August of the Golden Autumn, Lingrui Pharmaceutical was nominated the titles of "2020’s Healthy Chinese Brand"，"Top 100 in the Chinese Pharmaceutical Industry" and shortlisted the “3rd China OTC Brand Promotion Month”

Between August 13-17th 2020, the 2020 Cypress Conference was held in Boao, Hainan Province, China. The year’s theme being "Beginning a New Era of Life Cycle Health Management", Chairmen and General Managers of Lingrui Pharmaceutical Xiong Wei and Wu Huibin as well as others were invited to attend.

On the evening of August 14th, the Xipu Gold Award Ceremony was grandly held, and the annual health industry award "2020 Healthy Chinese Brand List" was announced. With its outstanding market performance and good public reputation, Lingrui Pharmaceutical was once again shortlisted for topical analgesics ranking, and won the Xipu Gold Award.

Meridian Obstruction Removing and Pain Relieving Plaster Patch is not only an exclusive product of Lingrui Pharmaceutical, but also a nationally protected product of traditional Chinese medicine. It has been repeatedly rated as the "Most Popular Rheumatology Orthopedic Medicine" and one of the "Top Ten Brands of Orthopedic Traumatology Chinese Patent Medicine" by industry experts. Appearing on the “Healthy China Brand List” is the topical medicine brand that has won the most awards; Lingrui Pediatric Fever Relieving Patch has made an appearance on the cutting-edge “Healthy China Brand List” three consecutive times, and is the only antipyretic patch brand to do so. 

On the evening of August 15th, Lingrui Pharmaceutical was awarded the honorable title of "Responsibility in Fighting the Epidemic with Great Love" by the Xipu Association. Since the beginning of the year, in the face of this sudden COVID epidemic, Lingrui Pharmaceutical has been resolved in demonstrating corporate social responsibility, in line with their philosophy of “establishing a business with integrity and benefiting mankind”. Responding quickly and actively, Lingrui has donated more than 10 million yuan to date in contribution to the fight against the epidemic.

external medicinal products such as Meridian Obstruction Removing and Pain-Relieving Plaster Patch, Musk Bone-strengthening and Pain-relieving Plaster Patch and Pain-relieving Tincture, etc. attracted a large number of guests to come and experience relaxing massages provided by the Lingrui staff. The advantages of combined medication with periodic administration in the treatment of nerve root cervical spondylosis, particularly with Lingrui’s "meridian obstruction removing” as well as “invigorate blood" products, were well-noted by the guests.

During the meeting, Xiong Wei and Wu Huibin conversed extensively with senior managers of many large pharmaceutical chains, including Gaoji , Yixintang, Quanyi, and Jiuzhou, on strategic co-operation between the parties.

On August 25, 2020, the 2020 China Pharmaceutical Industry Top 100 Annual Meeting was held in Kunming, Yunnan. The “2019 China Pharmaceutical Industry Top 100 Series List” was announced on the spot. Lingrui Pharmaceutical ranked 31st out of 100 due to its comprehensive strength, jumping up 9 places from the previous year and demonstrating the continued dedication to excellence of the company. This selection focuses on both the innovative prowess and professional leadership in industrial enterprises, where innovation has also been the main theme that development has been centered around at Lingrui Pharmaceutical.

On August 29, 2020, the 3rd China OTC Brand Promotion Month was held in Hangzhou, China. Lingrui’s "Pain-relieving Tincture" made an appearance as a promotional brand of the event.

The 2020 West Lake Forum held in July “Meridian Obstruction Removing and Pain-Relieving Plaster Patch” Won the Title of "The Most Popular Star Products in Pharmacies" in China

On July 12-15, the 2020 West Lake Forum for the Big Health Industry (the 11th China Medical Materials Association Chain Pharmacy Branch Annual Meeting) was held at the Wuzhen Internet Conference Center in Zhejiang Province. Lingrui Pharmaceutical was invited to participate in this event.

With the theme of "Meeting 2030", "2020 West Lake Forum" discussed the industrial trends and the development paths for the next 10 years under the Healthy China 2030 Plan.

In order to promote the development of Chinese medicine, this forum elected "the Most Popular Star Products in Pharmacies" to reward a batch of products with strong social influence, sales power and competitive ability in the retail sector. 

“Meridian Obstruction Removing and Pain-Relieving Plaster Patch”, the most famous product of Lingrui Pharmaceutical, won the title of "the Most Popular Star Product in Pharmacies". The patch was also in the "Big Health New Retail Brand List" announced on the evening of July 14, 2020.

“Meridian Obstruction Removing and Pain-Relieving Plaster Patch” has been promoted by OTC China Brand Promotion Month for two consecutive years. It has been rated as "Most Popular Rheumatology Orthopedic Medicine" and "Top Ten Brands of Chinese Patent Medicine in Orthopedics and Traumatology" by experts in the industry. Since 2004, “Meridian Obstruction Removing and Pain-Relieving Plaster Patch” has been repeatedly selected as a quality brand-name drug in the "Chinese Brand List".

2020 Strategic Cooperation Agreement Was Made by and between Lingrui Pharmaceutical and Jiuzhoutong Medical Group

On May 15, 2020, Henan Lingrui Pharmaceutical Co., Ltd. and Jiuzhoutong Medical Group held the 2020 strategic cooperation agreement signing ceremony and business communication meeting in the form of video conference. 

Since the strategic cooperation between Jiuzhoutong Medical Group and Lingrui Pharmaceutical in 2000, the high-level leaders of the two parties have visits and exchanges every year. Over the past 20 years, Jiuzhoutong Medical Group and Lingrui Pharmaceutical have cooperated and exchanged in various fields such as FBBC, logistics, warehousing, GSP certification, and the sales number of products through cooperation continues to break out to new highs. At present, Jiuzhoutong has become one of the Lingrui's largest strategic partners. 

At the video conference, the executives from two parties first reviewed the cooperation in recent years. From 2015 to 2019, both parties have continuously expanded new channels and new models of cooperation, and shared resources, creating a role model for mutual cooperation and win-win solution in the pharmaceutical industry. At the conference, the two parties also conducted in-depth exchanges on mutual concern such as smooth business connection and payment cycle, and reached an agreement. 

Both parties agreed that, at the same time of maintaining the current strong cooperation, they should strengthen chain cooperation, establish county alliances, deepen collaboration on primary medical affairs, develop e-commerce partnership, innovate business models, achieve overall goals, and push the cooperation to the next level. 

Lingrui Pharmaceutical and Jiuzhoutong Medical Group also exchanged views on the long-term development of the pharmaceutical market and the transformation of the pharmaceutical distribution industry. 

Paeonia Lactiflora is Blooming in Lingrui Chinese Herbal Medicine Base

It is early summer in China again and it is the season when Paeonia lactiflora begins to bloom. 

Recently, hundreds of acres of Paeonia lactiflora, in the Lingrui Chinese Herbal Medicine Base in Caowan Village, Xin County, Xinyang City, Henan Province, started to bloom, constituting a distinctive scenery. During the “May Day” holiday, tourists from nearby areas visited Caowan Village to enjoy the spectacular sight of this blooming.

The flowering stage of paeonia lactiflora lasts about half a month. Delightfully fragrant, the colorful flowers are also very ornamental. The roots of paeonia lactiflora are processed into Paeoniae Radix Alba and Radix Paeoniae Rrbra which are famous and valuable in Chinese herbal medicine.

The Lingrui Chinese Herbal Medicine Base is operated by Xinyang Lingrui Ecological Agriculture Co., Ltd., a subsidiary of Lingrui Pharmaceutical Co., Ltd., based on Chinese herbal medicine and other special resources in Xin County. It was established to meet the huge demands of the main raw materials used by the business of Lingrui Pharmaceutical Co., Ltd. 

The base occupies ​​350 acers and integrates scientific research, demonstration, and herbal planting as a whole, known in large-scale demonstration park. Currently the main kinds of plants, in the park, include herba belladonna, paeonia lactiflora, salvia miltiorrhizae, rhizoma corydalis, hot pepper, ginger and other varieties.

The base adopts the “company + base + farmers” business model to support and guide poor local households to plant Chinese herbal medicines. With increasing income from traditional Chinese herb planting, governmental assistance, and project dividends, previous poor households have gradually changed from “grain farmers” to “pharmaceutical farmers”. Working in the new industrial chain, they have been gotten rid of poverty and improved their lives tremendously. 

Henan Lingrui Pharmaceutical Donates to New Coronavirus Pneumonia Outbreak Prevention and Control

Since the outbreak of new coronavirus pneumonia in Wuhan in early 2020, the epidemic has continued to escalate. As a well-known pharmaceutical company, Lingrui immediately acted, set up a working group to support the epidemic area, and has taken a series of actions to help control and prevent the epidemic.

Lingrui Pharmaceutical organized employees as soon as possible to obtain protective supplies from domestic and foreign manufacturers, day and night. The first donation was launched on January 23th. 10,000 disposable medical masks were donated to Wuhan, Hubei Province on the 25th of January. 

On January 27th, after learning that Xin County, Henan Province where Lingrui is located, had a shortage of control materials, Lingrui Pharmaceutical quickly donated masks, disinfecting products, and antibacterial anti-inflammatory drugs to the Xin County Public Health Committee. 

On January 30th, Lingrui once again donated 1.2 million RMB worth of epidemic prevention materials and ￥500,000 in cash to Xinyang Epidemic Prevention Command and Xinyang Red Cross, for a total of 1.7 million RMB. 50,000 boxes of anti-inflammatory drugs are also on their way to Wuhan. 

Moreover, Lingrui Pharmaceutical is actively organizing the production of anti-epidemic Chinese medicines Qingshi granules and Kening capsules, which will be put on the market as soon as possible for the treatment of coronavirus!

The epidemic situation is still developing. The prevention and control work consume a large amount of medical supplies, resulting in a continuous shortage of protective supplies. 75% concentration of medical alcohol is one of the scarce supplies. Lingrui Pharmaceutical urgently called for production materials to expedite production of 75% concentration of medical alcohol. By adjusting the production line, Lingrui employees are working overtime to prepare 75% concentration of medical alcohol in various packaging specifications, and donating it to the relevant agencies in the epidemic areas. From January 27th, to January 31th, Lingrui Pharmaceutical has donated a total of 4 tons of 75% medical alcohol. 

From January 23th to January 31th, 2020, Lingrui Pharmaceutical has donated a total of 5 million RMB in masks, disinfectant alcohol and anti-inflammatory drugs, as well as preventive products and cash to Wuhan City, Hubei Province, Xinyang City and Xin County, Henan Province. In this battle against coronavirus, Lingrui will continue to cooperate with the national material deployment work, respond as quickly as possible, and work closely with the government and social enterprises to cooperate in the production of anti-inflammatory antibacterial drugs and disinfectants. At the same time, actively seek and contact medical material suppliers to ensure high-quality production and efficient supply to help the domestic epidemic areas overcome the coronavirus as soon as possible!

Lingrui Meridian Obstruction Removing and Pain Relieving Plaster Patch Proudly Chosen by “China’s First OTC Brand Awareness Month”

On June 23rd, 2018, “China’s First OTC Brand Awareness Month” launch ceremony was held in New Beijing People’s Daily Media Building. Henan Lingrui Pharmaceutical Co., Ltd. was invited to the event and showcased its leading product, Lingrui Meridian Obstruction Removing and Pain Relieving Plaster Patch. The product was praised and subsequently chosen by “China’s First OTC Brand Awareness Month” as a flagship promotional brand.

This event is co-sponsored by the Chinese Association of Non-prescription Drugs, China Pharmaceutical News Information Association, and the People’s Network Public Opinion Data Center. More than 20 well-known pharmaceutical companies at home and abroad participated, including Lingrui Pharmaceutical, SK&F, Bayer, and Pfizer. The event takes the theme of “Pharmaceutical Brands Around Me” to build an authoritative OTC promotion platform. By cohesion of industry forces to create brand synergy, it gives the public more insight into the OTC brand as a whole, and enables medicine to ultimately better serve public health.

The event officially released “China’s Non-Prescription Drug Industry Brand Integrity Statement”. It awarded outstanding OTC brand companies; well recognized by the industry and adhering to honest management and public interest. It is reported that after the organizing committee’s multi-angle review and assessment, 25 well-known OTC brand companies were shortlisted for “China’s First OTC Brand Awareness Month” as a promotional brand. Lingrui Pharmaceutical was honored to be among them.

As the state nominated winner of the. “High-Tech Enterprise and National Quality Award”, Lingrui is committed to the pharmaceutical industry and protecting human health. Lingrui Meridian Obstruction Removing and Pain Relieving Plaster Patch is an external plaster medicine for the treatment of osteoarthritis and cervical spondylosis. It is under the Protected Varieties of Traditional Chinese Medicine, as well as being a unique pharmaceutical product with an annual sales volume of over 500 million yuan in the industry. With good reputation and curative effect, it is both popular and occupies a significant portion of market share; trusted and recommended by both customers and retail pharmacies alike. It is also listed on the “Healthy China • China Brand List” for consecutive years since 2008.

Lingrui U.S. and ShanCha Inc. Present at 2018 China Fashion Gala

On May 4, 2018 in New York, Lingrui Pharmaceutical U.S. R&D Center and ShanCha Inc. jointly participated in the 2018 China Fashion Gala hosted at The Plaza Hotel, a famous landmark hotel in New York City. The event was sponsored by both the China Institute and the Yue-Sai Kan China Beauty Charity Fund.

China Institute is a non-profit folk culture and art organization jointly established by world-renowned scholars Hu Shih, Dr. K. P. Wen, and distinguished education scholars John Dewey and Paul Monroe of Columbia University.

The Yue-Sai Kan China Beauty Charity Fund is an organization under China Soong Ching Ling Foundation dedicated to "the betterment and advancement of women and children through education, health and cultural programs worldwide". Ms. Kan is the image ambassador and executive chairman of the fund.

The event invited director of China Institute Mr. Pei Jianzhong, son of famous architect I. M. Pei, and Mr. Abigail Posner, creative director of Google to deliver a speech.

Mr. Xiong Weizheng, President of Lingrui Group, served as a member of the event's hosting committee.

As a major sponsor, Lingrui joined hands with world-renowned brands such as Tiffany & Co., Van Cleef & Arpels, mainstream commercial organization Citibank and United Airlines in the event.

The cocktail reception launched at the beginning of the event showcases the photography and paintings of modern Chinese artist Sun Jun. The formal banquet opened with dance performances by 6 Chinese winners of the Miss Universe beauty pageant.Other programs include fashion legacy award presentations by luxury jewelry brand Tiffany & Co., high-end footwear retailer Christian Louboutin and premiere custom fashion designer Shanghai Tang.

There was also Fashion Icon Awards Presentation hosted by celebrity Maggie Q. Renowned Chinese designer Grace Chen revealed her new fashion line to a captivated audience.

The purpose of the event is to provide exposure for Chinese fashion to the world, inspire more innovative designers to use Chinese elements, and revitalize the field of art fashion with new energy.

ShanCha Inc. donated a 1-year platinum membership to the auction and provided guests with a beautiful gift – a Camellia Legend ® gift box which dazzled attendants.

Lingrui Group is an active participant in China's Commercial Innovation and Head to World project. Under this initiative, ShanCha Inc. recently launched the skincare brand Camellia Legend®. This marks the first time that the company received public recognition in the fashion world.

As a member of the line of ShanCha® body care products, Camellia Legend® arrived just in time, combining natural organic materials and cutting-edge US R&D. It is a solution to various skin problems, improves skin texture and brings beauty from the inside out.

Lingrui Debuts at Shanghai Exhibition Center - The World Loves Chinese Brands

On May 10, 2018, the first ever "Chinese Brand Day" was held and co-sponsored by a number of Chinese government departments. The grand opening was kicked off with a series of activities at the Shanghai Exhibition Center. 

The “Chinese Brand Day" series featured “The World Loves Chinese Brands” as the theme and brought together the proudest national brands of China. Across the country, there were more than 50 exhibition delegations, 600 domestic famous brand enterprises, more than 100 innovative SMEs and 20 brand service organizations present at the exhibition, showing the world the charm and allure of Chinese brands. 

After more than two decades of development and growth, Lingrui Pharmaceutical has finally developed a group and scale operation trend; with promising technological innovation initiatives, industrial chain integrating production, as well as research and development. The Group owns a number of scientific research and production sites. Among them, the Plaster Division located in Lingrui Eco-Industrial Park in Xin County is the largest production site for external medicine in China. After expansion, it will be able to produce billions of paste plaster products annually. The Lingrui Xinyang Health Industrial Park is currently serving as an advanced and large-scale oral domestic drug production site.

The Lingrui Beijing Pharmaceutical Research Institute and the National Enterprise Technology Center are the company’s scientific and technological research and development sites. The total assets of the company amount to more than 3 billion RMB yuan with nearly 6,000 employees. Its annual profit tax reached 500 million RMB yuan which acts as a strong support pillar to the development of the local social economy. 

In recent years, under the leadership of General Manager of Ling Rui Pharmaceutical Xiong Wei, the management team successfully and proactively adapted to the new economic setting through continuous reform and innovation. They adhered to the modernization and development of the health industry, adding special features to the main plaster products as well as vigorously implementing their brand innovation strategies. They strive to make Lingrui the number one brand in the industry. Lingrui Pharmaceuticals also makes full use of its brand, capital, talent and technical advantages while focusing on its main products; winning the "Healthy China Brands List" for 6 consecutive years. With the motto of “Higher standards of quality in the global health industry, strengthening and expanding Lingrui brand”, Lingrui seized the opportunities to implement the differentiation, technology, management innovation, resource integration and capital operation needed to succeed. Endless innovation and development mean that the company is actively involved in many fields, such as financial investment, medicine, healthcare, agriculture and forestry industry processing. It presents a good trend of sustained and healthy development that opens a new chapter in the secondary entrepreneurship of Lingrui. 

The Lingrui Pharmaceutical production management team regards product quality as a top priority. It strictly follows the GMP standard for production and meticulously performs three levels of quality inspection procedures. The supplier management system is adhered to with extreme diligence. A joint working group, composed of multiple departments, has been set up specifically with rigorous dynamic management by conducting a full range of field visits to suppliers from qualifications, scale, and quality control staff. At the same time, the company continues to strengthen technological innovation and product development capabilities. Post-doctoral Research Stations, Academician Workstations, and a nationally recognized enterprise technology center have been established. It has improved product quality inspections and testing significantly, in order to ensure quality. 

By relying on scientific and technological innovation and implementing brand strategy, the brand image of Lingrui has been continuously growing. The main products of the company, such as Meridian Obstruction Removing and Pain Relieving Plaster Patch (Bone Hyperostosis Relief Plaster), Stomach Ache-Free Tablets, Musk Bone-strengthening and Pain-relieving Plaster Patch were named as Henan Famous Brand Products. Stomach Ache-Free Tablets also won the National New Product New Technology Expo Gold Award. The Meridian Obstruction Removing and Pain Relieving Plaster Patch (Bone Hyperostosis Relief Plaster) and Cerebral Circulation Reinvigoration and Restoration Capsules were identified as "National Community Health Education Model Products”. The company has received "National Top 50 Chinese Medicine Enterprise" and "National Enterprise Technology Center" as well as other honors. 

With “Integrity and accountability for the benefit of mankind” as the company vision, Lingrui is committed to building China's excellent pharmaceutical reputation as the first brand for transdermal patches in China, and the world at large.

Beauty’s Energy: Camellia Legend ®

Camellia Legend ®

Camellia oil is made by cold-press from the camellia fruit, grown only in China and Japan. It is rich in natural vitamins, minerals, high-quality unsaturated fatty acids, plant collagen and antioxidants. Its preciousness and health benefits have been known for thousands of years. 

Camellia oil contains unique molecules that make it light and mild. It is edible, contains nutrients for natural moisturizing, is firming and anti-inflammatory (making it easy to penetrate and moisturize the skin), locks in hydration, and softens fine lines that come with age.

The elastin and collagen in Camellia oil can stimulate cell renewal, restore smoothness and firmness of the skin, delay aging, as well as heal scars. Camellia oil also has excellent penetration characteristics for hair and is a natural and healthy hair growth agent. 

Asian women have been well aware of the magic of camellia oil on the skin and hair. It is their secret to everlasting beauty. 

Henan Lingrui Group in China is committed to the development of organic, healthy, and edible camellia oil. Based on this concept, it focuses on products that unleash each individual’s inner beauty! 

After years of research and development, a 2018 collaboration with American scientists led to the launch of a unique product line of Camellia Oil Skin Care – Camellia Legend®. With a modern formula, the magical effect was even more magnificent; a fusion of nature and science, camellia oil radiates with beautiful energy. 

All Camellia Legend products are rich in camellia extract originated from the wild ancient camellia forest of Xin County in the hinterland of China's Dabie Mountains，gentle and pure, it is the ultimate companion in the journey for everlasting beauty.

 

Camellia Legend® Products

Camellia Vitamin C Jelly – A Morning Boost and a Night Recovery

The Vitamin C jelly is enriched with camellia extract. We designed an innovative formula concept in which the Vitamin C is micro-emulsified which helps to stabilize and deliver it. The micro-emulsion will penetrate the skin faster than a regular emulsion, which helps Vitamin C to perform at optimum efficacy. The jelly can help to smooth down wrinkles, stimulating cell renewal and brighten the skin.

Camellia Oil Face Firming Serum – Give Your Face a Lift, Promote a Youthful Appearance

The Face Firming Serum is powered by innovated technology that delivers camellia oil and its actives in the most potent and efficacious way to the right skin receptors. It also contains Hyaluronic Acid, an anti-aging gold standard combined with the natural antibiotics, which is an encapsulated form of this powerful anti-oxidant ingredient. They work synergistically to reduce irritation and inflammation caused by radicals. Therefore to soothe wrinkles, reduce the appearance of visible pigmentation and enhance skin firmness. This brand new innovative formula helps to slow down aging.

Camellia Oil Clear and Rejuvenate Serum – Sub-Micron Structure for Severe Acne Relief

This serum carries dual-action of anti-blemish and dark spot corrector. The Linoleic Acid contained in camellia oil balances the skin and repairs skin flaws and scars. The antioxidant can effectively counter hyperpigmentation. A time release of Salicylic Acid reduces blemishes. The gentle exfoliation helps expose skin’s youthful radiance and clarity. Our advanced technology keeps the multiple ingredients from counteracting one another and time releases them to maximize efficiency.

Camellia Oil Ageless Retinol Custard – Enhance Firmness and Boost Hydration

Camellia is known for its powerful antibiotics and anti-oxidant profile. Retinol as the gold standard ingredient can smooth wrinkles, stimulate cell renewal. Our unique encapsulation technology can not only protect Retinol from oxidation but also deliver it to the right skin receptor in the most potent and efficacious way. All the active ingredients are encapsulated in the core. By stimulating the production of collagen, elastin, and glycosaminoglycan this lotion can effectively reduce fine lines around eyes and promote a youthful appearance.

Camellia Oil Clarifying Mask - A Powerful Nourish Formula

Our Camellia Oil Clarifying Mask is powered with proprietary encapsulation technology that delivers actives in the most potent and efficacious way without causing skin irritation. Camellia oil contains high-quality unsaturated fatty acids, skin vitamins, polyphenols and other nutrients to exert anti-inflammatory and anti-oxidant effects and absorb deep toxins in the skin. The encapsulated form of Salicylic Acid was designed to laser-target the sites of bacterial infection and deep clean the skin. Oxygen-releasing species delivers oxygen to the skin receptors to assist the cells with the energy production. The super stable form of Vitamin C helps with the overall skin healing and improvement.

Camellia Anti-Aging Hand Scrub – Pamper Your Hands the Same Way

This is a luxurious formula. The role is not limited to moisturizing. The Squalene contained in camellia oil helps reinforce the skin’s barrier. The formula also offers a gentle chemical exfoliation using Lactic Acid combined with a mechanical exfoliation using Jojoba Beads which blocks the melanosomes transfer and reduces visible dark spots. Hyaluronic Acid, an anti-aging gold standard, help to rejuvenate skin through stimulation of cell renewal, prevents visible hyperpigmentation, addressing signs of aging, hyperpigmentation, and loose, dry skin.

All Camellia Legend products are rich in camellia extract originated from the wild ancient camellia forest of Xin County in the hinterland of China's Dabie Mountains, gentle and pure, it is the ultimate companion in the journey for everlasting beauty.